Long Non-coding RNAs in Cancer Invasion and Metastasis

Overview

Journal Mod Pathol

Specialty Pathology

Date 2014 Jun 14

PMID 24925053

Citations 49

Authors

Xiao-Han Shen

Peng Qi

Xiang Du

Affiliations

Soon will be listed here.

Abstract

Recent large-scale transcriptome analyses have revealed that the human genome contains more than just protein-coding genes. Indeed, a large number of transcripts, including long non-coding RNAs (lncRNAs), lack protein-coding capacity, and increasing evidence suggests that lncRNAs could have a critical role in the regulation of diverse cellular processes, such as stem cell pluripotency, development, cell growth and apoptosis, and cancer invasion and/or metastasis. Furthermore, the aberrant expression of several lncRNAs is closely linked to cancer invasion and/or metastasis. Although the underlying molecular mechanisms by which lncRNAs regulate cancer invasion and/or metastasis are not clearly understood, recent studies have revealed that aberrant lncRNAs expression affects the progression of cancer. In this review, we highlight recent findings regarding the roles of lncRNAs in cancer invasion and/or metastasis.

Citing Articles

HOTTIP rs1859168 C > A polymorphism reduces neuroblastoma susceptibility in Chinese children.

Zhang T, Yin H, Guo J, Chang J, Li M, He J Eur J Pediatr. 2024; 184(1):104.

PMID: 39718648 DOI: 10.1007/s00431-024-05942-4.

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.

Wojtukiewicz M, Mysliwiec M, Tokajuk A, Kruszewska J, Politynska B, Jamroze A Cancer Metastasis Rev. 2024; 43(4):1185-1204.

PMID: 39153052 PMC: 11554837. DOI: 10.1007/s10555-024-10205-7.

Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.

Meng X, Bai X, Ke A, Li K, Lei Y, Ding S Biomolecules. 2024; 14(6).

PMID: 38927012 PMC: 11201466. DOI: 10.3390/biom14060608.

Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).

Huang Q, Liang Z, Huang Q, Li X, Xia J, Huang L Oncol Rep. 2024; 51(6).

PMID: 38666534 PMC: 11082637. DOI: 10.3892/or.2024.8743.

The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.

Feichtenschlager V, Chen L, Zheng Y, Ho W, Sanlorenzo M, Vujic I Mol Cancer. 2024; 23(1):40.

PMID: 38383439 PMC: 10882889. DOI: 10.1186/s12943-024-01955-7.

References

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F . Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012; 8(9):2289-94. DOI: 10.1039/c2mb25070e. View

Yang F, Huo X, Yuan S, Zhang L, Zhou W, Wang F . Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013; 49(6):1083-96. DOI: 10.1016/j.molcel.2013.01.010. View

Nguyen V, Kiss T, Michels A, Bensaude O . 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature. 2001; 414(6861):322-5. DOI: 10.1038/35104581. View

Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson E, Polette M . Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia. 2010; 15(2):261-73. DOI: 10.1007/s10911-010-9174-0. View

Chen F, Sun M, Li S, Wu Q, Ji L, Liu Z . Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 2013; 52(11):908-15. DOI: 10.1002/mc.21944. View

Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L . CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014; 35(6):5375-80. DOI: 10.1007/s13277-014-1700-z. View

Prensner J, Rubin M, Wei J, Chinnaiyan A . Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med. 2012; 4(127):127rv3. PMC: 3799996. DOI: 10.1126/scitranslmed.3003180. View

Logue J, Morrison D . Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev. 2012; 26(7):641-50. PMC: 3323875. DOI: 10.1101/gad.186965.112. View

Brito G, Fachel A, Vettore A, Vignal G, Gimba E, Campos F . Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma. Mol Carcinog. 2008; 47(10):757-67. DOI: 10.1002/mc.20433. View

10.

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

11.

Madamanchi N, Hu Z, Li F, Horaist C, Moon S, Patterson C . A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis. Biochim Biophys Acta. 2002; 1576(3):237-45. DOI: 10.1016/s0167-4781(02)00308-1. View

12.

Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, de-Groot N . Possible physiological role of H19 RNA. Mol Carcinog. 2002; 35(2):63-74. DOI: 10.1002/mc.10075. View

13.

Zhao Y, Shen S, Guo J, Chen H, Greenblatt D, Kleeff J . Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. J Surg Res. 2006; 136(2):325-35. DOI: 10.1016/j.jss.2006.06.031. View

14.

Qi P, Xu M, Ni S, Shen X, Wei P, Huang D . Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol Carcinog. 2014; 54(9):742-50. DOI: 10.1002/mc.22137. View

15.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

16.

Huarte M, Guttman M, Feldser D, Garber M, Koziol M, Kenzelmann-Broz D . A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010; 142(3):409-19. PMC: 2956184. DOI: 10.1016/j.cell.2010.06.040. View

17.

Baldassarre A, Masotti A . Long non-coding RNAs and p53 regulation. Int J Mol Sci. 2012; 13(12):16708-17. PMC: 3546715. DOI: 10.3390/ijms131216708. View

18.

Tahira A, Kubrusly M, Faria M, Dazzani B, Fonseca R, Maracaja-Coutinho V . Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer. 2011; 10:141. PMC: 3225313. DOI: 10.1186/1476-4598-10-141. View

19.

Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F . Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190(6):2278-87. DOI: 10.1016/j.juro.2013.07.001. View

20.

Calhoun E, Jones J, Ashfaq R, Adsay V, Baker S, Valentine V . BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol. 2003; 163(4):1255-60. PMC: 1868306. DOI: 10.1016/S0002-9440(10)63485-2. View